Literature DB >> 27966079

Anti-Apoptotic Effect of IGF1 on Schwann Exposed to Hyperglycemia is Mediated by Neuritin, a Novel Neurotrophic Factor.

Lingfei Yan1, Min Xie1, He Lu1, Hongman Zhang1, Min Shi1, Yingduan Zhang1, Chunhong Xi1, Jianbo Li2,3, Tao Yang1.   

Abstract

The aim of the present study is to explore the effects of exogenous insulin-like growth factor-1 (IGF1) on hyperglycemia-induced apoptosis of Schwann cells via neuritin-mediated pathway. Neuritin was identified with immunohistochemistry. Exogenous IGF1 was used to prevent possible changes in neuritin expression and apoptosis of Schwann cells isolated from rat sciatic nerves and cultured in high-glucose media. Neuritin silencing or overexpressing lentivirus transfection of Schwann cells was conducted. Expressions of neuritin at levels of transcription or translation were measured using quantitative PCR or Western blot. Caspase-3 and caspase-9 fluorometric assays were performed. Bcl-2 and Bax were assayed using Western blotting. Apoptosis of Schwann cells was measured using FACS analysis and TUNEL assay. A pathway of IGF1 action in relation to neuritin was explored. Neuritin and Bcl-2 protein were localized in Schwann cells of rats' sciatic nerves. In vitro, apoptosis increased with downregulated neuritin expression, which was prevented by exogenous IGF1 treatment in contrast to without, in Schwann cells isolated from rat sciatic nerve and cultured in high-glucose and serum-free media. A phosphatidylinositol-3-kinase (PI3K) inhibitor treatment blocked the action of IGF1. The inhibitor did not affect the apoptosis rate that decreased obviously after neuritin was overexpressed in Schwann cells. The apoptosis rate increased drastically after neuritin was silenced, and the resultant apoptosis was suppressed by a caspase inhibitor treatment but not affected by exogenous IGF1. The activities of caspase-3 and caspase-9 changed positively with apoptosis. An anti-apoptotic protein (Bcl-2) not Bax increased or decreased in neuritin-overexpressed or neuritin-silenced Schwann cells, respectively. Bcl-2-selective inhibitor blocked the anti-apoptotic effect of neuritin. IGF1 or neuritin was not found to affect glucose levels in media during the experiment. The anti-apoptotic effect of IGF1 on Schwann cells inflicted by hyperglycemia is mediated at least by neuritin, a novel neurotrophic factor, through PI3K and Bcl-2.

Entities:  

Keywords:  Hyperglycemia; IGF1; Neuritin expression; Schwann cell survival

Mesh:

Substances:

Year:  2016        PMID: 27966079     DOI: 10.1007/s12035-016-0331-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

1.  Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis.

Authors:  Ulrich Putz; Corey Harwell; Elly Nedivi
Journal:  Nat Neurosci       Date:  2005-02-13       Impact factor: 24.884

2.  A new method of selecting Schwann cells from adult mouse sciatic nerve.

Authors:  Michael E Pannunzio; I-ming Jou; Andrew Long; Tyler C Wind; Gina Beck; Gary Balian
Journal:  J Neurosci Methods       Date:  2005-06-20       Impact factor: 2.390

3.  Influence of hyperglycemia on oxidative stress and matrix metalloproteinase-9 activation after focal cerebral ischemia/reperfusion in rats: relation to blood-brain barrier dysfunction.

Authors:  Hiroshi Kamada; Fengshan Yu; Chikako Nito; Pak H Chan
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

Review 4.  Schwann cells: origins and role in axonal maintenance and regeneration.

Authors:  Kanav Bhatheja; Jeffrey Field
Journal:  Int J Biochem Cell Biol       Date:  2006-05-27       Impact factor: 5.085

5.  ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets.

Authors:  Andrew J Souers; Joel D Leverson; Erwin R Boghaert; Scott L Ackler; Nathaniel D Catron; Jun Chen; Brian D Dayton; Hong Ding; Sari H Enschede; Wayne J Fairbrother; David C S Huang; Sarah G Hymowitz; Sha Jin; Seong Lin Khaw; Peter J Kovar; Lloyd T Lam; Jackie Lee; Heather L Maecker; Kennan C Marsh; Kylie D Mason; Michael J Mitten; Paul M Nimmer; Anatol Oleksijew; Chang H Park; Cheol-Min Park; Darren C Phillips; Andrew W Roberts; Deepak Sampath; John F Seymour; Morey L Smith; Gerard M Sullivan; Stephen K Tahir; Chris Tse; Michael D Wendt; Yu Xiao; John C Xue; Haichao Zhang; Rod A Humerickhouse; Saul H Rosenberg; Steven W Elmore
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

6.  Human and rat adult Schwann cell cultures: fast and efficient enrichment and highly effective non-viral transfection protocol.

Authors:  Kirsten Haastert; Christina Mauritz; Sukhada Chaturvedi; Claudia Grothe
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

7.  Gene expression of antioxidant enzymes in experimental diabetic neuropathy.

Authors:  Y Kishi; K K Nickander; J D Schmelzer; P A Low
Journal:  J Peripher Nerv Syst       Date:  2000-03       Impact factor: 3.494

8.  Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway.

Authors:  Takeshi Suzuki; Hiromi Sekido; Noriaki Kato; Yukiharu Nakayama; Chihiro Yabe-Nishimura
Journal:  J Neurochem       Date:  2004-12       Impact factor: 5.372

9.  Expression of liver insulin-like growth factor 1 gene and its serum level in patients with diabetes.

Authors:  Jian-Bo Li; Cheng-Ya Wang; Jia-Wei Chen; Zhen-Qing Feng; Hong-Tai Ma
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

Review 10.  How does glucose generate oxidative stress in peripheral nerve?

Authors:  Irina G Obrosova
Journal:  Int Rev Neurobiol       Date:  2002       Impact factor: 3.230

View more
  8 in total

1.  TCR-pMHC encounter differentially regulates transcriptomes of tissue-resident CD8 T cells.

Authors:  Akihiro Yoshizawa; Kevin Bi; Derin B Keskin; Guanglan Zhang; Bruce Reinhold; Ellis L Reinherz
Journal:  Eur J Immunol       Date:  2017-09-29       Impact factor: 5.532

Review 2.  Functions and the related signaling pathways of the neurotrophic factor neuritin.

Authors:  Jin-Jing Yao; Qian-Ru Zhao; Jun-Mei Lu; Yan-Ai Mei
Journal:  Acta Pharmacol Sin       Date:  2018-03-29       Impact factor: 6.150

3.  miR-129 controls axonal regeneration via regulating insulin-like growth factor-1 in peripheral nerve injury.

Authors:  Hui Zhu; Chengbin Xue; Min Yao; Hongkui Wang; Ping Zhang; Tianmei Qian; Songlin Zhou; Shiying Li; Bin Yu; Yongjun Wang; Xiaosong Gu
Journal:  Cell Death Dis       Date:  2018-06-18       Impact factor: 8.469

4.  Neuritin promotes neurite and spine growth in rat cerebellar granule cells via L-type calcium channel-mediated calcium influx.

Authors:  Qian-Ru Zhao; Jun-Mei Lu; Zhao-Yang Li; Yan-Ai Mei
Journal:  J Neurochem       Date:  2018-08-16       Impact factor: 5.372

5.  Exogenous neuritin treatment improves survivability and functions of Schwann cells with improved outgrowth of neurons in rat diabetic neuropathy.

Authors:  Chunhong Xi; Yingduan Zhang; Mei Yan; Qing Lv; Huan Lu; Jun Zhou; Yucheng Wang; Jianbo Li
Journal:  J Cell Mol Med       Date:  2020-07-15       Impact factor: 5.310

6.  Sustainable Release of Propranolol Hydrochloride Laden with Biconjugated-Ufasomes Chitosan Hydrogel Attenuates Cisplatin-Induced Sciatic Nerve Damage in In Vitro/In Vivo Evaluation.

Authors:  Yasmin M Ahmed; Raha Orfali; Doaa S Hamad; Mostafa E Rateb; Hanan O Farouk
Journal:  Pharmaceutics       Date:  2022-07-23       Impact factor: 6.525

7.  Decreased Level of Neurotrophic Factor Neuritin 1 in Women with Ovarian Endometriosis after Receiving Gonadotropin-Releasing Hormone Agonist Treatment.

Authors:  Endah Rahmawati; Wei-Chung Vivian Yang; Yen-Ping Lei; Pawan Kumar Maurya; Huei-Wen Chen; Chii-Ruey Tzeng
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

8.  A Metabolic Insight Into the Neuroprotective Effect of Jin-Mai-Tong (JMT) Decoction on Diabetic Rats With Peripheral Neuropathy Using Untargeted Metabolomics Strategy.

Authors:  Qian Zhang; Wei Song; Xiaochun Liang; Jun Xie; Yue Shi; Xiaohu Shi; Bintao Qiu; Xiuting Chen
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.